Actualizar mis citas con la selección
Presentar
resultados
Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd C, Criner GJ, Donaldson GC, Dreher M, Fan VS, Gershon AS, et al..
Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline .
Am J Respir Crit Care Med 2020;201:1 de mayo. [Ref.ID 103620]
Chapman KR, Hurst JR, Frent SM, Larbiq M, Fogel R, Guerin T, Banerji D, Patalano F, Goyal P, Pfister P, Kostikas K, Wedzicha JA.
Long-term triple therapy de-escalation to indacaterol/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind, triple-dummy clinical trial.
Am J Respir Crit Care Med 2018;198:1 de agosto. [Ref.ID 102826]
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A.
Extensive impact of non-antibiotic drugs on human gut bacteria.
Nature 2018;555:29 de marzo. [Ref.ID 102577]
Velzel J, Vlemmix F, Opmeer BC, Molkenboer JFM, Verhoeven CJ, van Pampus MG, Papatsonis DNM, Bais JMJ, Vollebregt KC, van der Esch L, van der Post JAM, Mol BW, Kok M.
Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial.
BMJ 2017;356:i6773. [Ref.ID 101398]
Actualizar mis citas con la selección